Medicare Coverage.

“This Medicare contractor will provide limited coverage for the myPath Melanoma assay for the diagnosis or exclusion of melanoma from a biopsy…”

MolDX: myPath Melanoma Assay (L37881), effective date 4/29/2019

Register to Download PDF

NCCN® Clinical Guidelines – Melanoma

“Consider the use of molecular testing for histologically equivocal lesions.”

National Comprehensive Cancer Network Guidelines Version 2.2019 – Melanoma

More Info